Ferric pyrophosphate citrate administered via dialysate reduces erythropoiesis-stimulating agent use and maintains hemoglobin in hemodialysis patients
2015 ◽
Vol 30
(12)
◽
pp. 2019-2026
◽
2016 ◽
Vol 38
(10)
◽
pp. 2318-2323
◽
2016 ◽
Vol 36
(2)
◽
pp. 124-129
◽
2016 ◽
Vol 57
(3)
◽
pp. 312-320
◽
2016 ◽
Vol 103
(5)
◽
pp. 1252-1259
◽
2018 ◽
Vol 33
(suppl_1)
◽
pp. i300-i300